Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
Interdisciplinary Toxicology|November 26, 2019
Assessment of the time-dependent dermatotoxicity of mechlorethamine using the mouse ear vesicant modelBenedette J Cuffari, Hemanta C Rao Tumu, Maria A Pino, et al.Cancer Biology & Therapy|December 24, 2002
A naturally occurring allele of BRCA1 coding for a temperature-sensitive mutant proteinTerri Worley, Johan Vallon-Christersson, Blase Billack, et al.Journal of Biochemical and Molecular Toxicology|May 8, 2013
Ebselen reduces the toxicity of mechlorethamine in A-431 cells via inhibition of apoptosisAnju Lulla, Maria A Pino, Magdalena Piętka-Ottlik, et al.AAPS Pharmscitech|July 2, 2026
Enhanced Stability and Transdermal Delivery of Semaglutide Using an L-Arginine Based Dissolving Microneedle SystemPriyanka Panchal, Snehal Daware, Yi Guo, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|March 10, 2010
Evaluation of the antifungal and plasma membrane H+-ATPase inhibitory action of ebselen and two ebselen analogs in S. cerevisiae culturesBlase Billack, Magdalena Pietka-Ottlik, Michelle Santoro, et al.Cancer Biology & Therapy|December 24, 2002
Mutations in the BRCT domain confer temperature sensitivity to BRCA1 in transcription activationMarcelo A Carvalho, Blase Billack, Emily Chan, et al.Nanomedicine (London, England)|September 19, 2023
Nanoformulation of a novel potent ebselen analog for treatment of vulvovaginal candidiasisXiuyi Liang, Suvidha Menon, Richa Vartak, et al.Current Research in Toxicology|September 17, 2024
Investigation of inflammatory mechanisms induced by croton oil in mouse earGanming Mao, Dalon Douglas, Milankumar Prajapati, et al.Drug and Chemical Toxicology|September 27, 2018
Ebselen oxide attenuates mechlorethamine dermatotoxicity in the mouse ear vesicant modelHemanta C Rao Tumu, Benedette J Cuffari, Maria A Pino, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 23, 2023
Oral lipid nanocomplex of BRD4 PROteolysis TArgeting Chimera and vemurafenib for drug-resistant malignant melanomaAishwarya Saraswat, Richa Vartak, Rehab Hegazy, et al.Pageof 5